|
John Campbell, Campbell Alliance
|
|
|
|
"Specialized consultants will have the opportunity to work on a larger volume of strategic and operationally focused projects. Clients will increasingly focus on receiving value for their money"
|
|
|
|
Michael Eckstut and Nancy Bergsteinsson; Archstone Consulting
|
|
|
|
"Increased outsourcing will yield lower costs, but also will increase the potential for risk (less control of suppliers, materials, and raining), as well as less flexibility when it comes to responding to business changes"
|
|
|
|
Gadi Saarony, Parexel Consulting
|
|
|
|
Typically, companies have outsourced back-office operations or routine activities. Now they should be thinking about partnering to obtain strategic capabilities.
|
|
|
|
Claude Allary, Frederic Desdouits, Alain J. Gilbert; Bionest Partners
|
|
|
|
Most of the innovative products are now coming from hundreds of emerging companies worldwide. The objective is no longer solely to identify the right asset, but to get access and secure it through more and more complex deals and value-sharing partnerships
|
|
|
|
Raymond Hill, IMS
|
|
|
|
Evidence-based consultants can, for example, access data rapidly, analyze it, and extract critical strategic and market insights - while traditional players are still turning to others for data and, often, insights.
|
|
|
|
Phil Garland, BearingPoint
|
|
|
|
The theme for the pharmaceutical and biotech industries in 2009 is change.
|
|
|
|
Eduardo Schur, Navigant Consulting
|
|
|
|
Despite all the pressures on pharma, and its increasingly competitive marketplace, the outlook for the industry continues to be positive.
|
|
|
|
Robert Shewbrooks, TGaS Advisors
|
|
|
|
Comm op can offer valuable strengths for difficult times - analytic, systematic, managerial, and strategic - and provide an untapped resource for senior management.
|
|
|